These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8723491)

  • 1. Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors.
    Hastings JC; Selnick H; Wolanski B; Tomassini JE
    Antimicrob Agents Chemother; 1996 May; 40(5):1304-7. PubMed ID: 8723491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel antiviral agent which inhibits the endonuclease of influenza viruses.
    Tomassini JE; Davies ME; Hastings JC; Lingham R; Mojena M; Raghoobar SL; Singh SB; Tkacz JS; Goetz MA
    Antimicrob Agents Chemother; 1996 May; 40(5):1189-93. PubMed ID: 8723464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.
    Tomassini J; Selnick H; Davies ME; Armstrong ME; Baldwin J; Bourgeois M; Hastings J; Hazuda D; Lewis J; McClements W
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2827-37. PubMed ID: 7695269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.
    Baughman BM; Jake Slavish P; DuBois RM; Boyd VA; White SW; Webb TR
    ACS Chem Biol; 2012 Mar; 7(3):526-34. PubMed ID: 22211528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit.
    Noshi T; Kitano M; Taniguchi K; Yamamoto A; Omoto S; Baba K; Hashimoto T; Ishida K; Kushima Y; Hattori K; Kawai M; Yoshida R; Kobayashi M; Yoshinaga T; Sato A; Okamatsu M; Sakoda Y; Kida H; Shishido T; Naito A
    Antiviral Res; 2018 Dec; 160():109-117. PubMed ID: 30316915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models.
    Fukao K; Ando Y; Noshi T; Kitano M; Noda T; Kawai M; Yoshida R; Sato A; Shishido T; Naito A
    PLoS One; 2019; 14(5):e0217307. PubMed ID: 31107922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance.
    Nannetti G; Massari S; Mercorelli B; Bertagnin C; Desantis J; Palù G; Tabarrini O; Loregian A
    Antiviral Res; 2019 May; 165():55-64. PubMed ID: 30885750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyunsaturated fatty acids from Phyllocaulis boraceiensis mucus block the replication of influenza virus.
    de Toledo-Piza AR; de Oliveira MI; Negri G; Mendonça RZ; Figueiredo CA
    Arch Microbiol; 2018 Aug; 200(6):961-970. PubMed ID: 29616305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel multiple kinase inhibitor with potent antiviral activity against influenza virus by reducing viral polymerase activity.
    Sasaki Y; Kakisaka M; Chutiwitoonchai N; Tajima S; Hikono H; Saito T; Aida Y
    Biochem Biophys Res Commun; 2014 Jul; 450(1):49-54. PubMed ID: 24858693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors.
    Jones JC; Kumar G; Barman S; Najera I; White SW; Webby RJ; Govorkova EA
    mBio; 2018 Apr; 9(2):. PubMed ID: 29691337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and mechanisms of anti-influenza virus metabolites isolated from the Vietnamese medicinal plant Polygonum chinense.
    Tran TT; Kim M; Jang Y; Lee HW; Nguyen HT; Nguyen TN; Park HW; Le Dang Q; Kim JC
    BMC Complement Altern Med; 2017 Mar; 17(1):162. PubMed ID: 28327126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of natural flutimide and analogous fully substituted pyrazine-2,6-diones, endonuclease inhibitors of influenza virus.
    Singh SB; Tomassini JE
    J Org Chem; 2001 Aug; 66(16):5504-16. PubMed ID: 11485475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities.
    Smee DF; Huffman JH; Morrison AC; Barnard DL; Sidwell RW
    Antimicrob Agents Chemother; 2001 Mar; 45(3):743-8. PubMed ID: 11181354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of influenza viruses replication: a patent evaluation (WO2013019828).
    Xie Y; Song W; Xiao W; Gu C; Xu W
    Expert Opin Ther Pat; 2013 Nov; 23(11):1517-24. PubMed ID: 23967861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An efficient screening system for influenza virus cap-dependent endonuclease inhibitors.
    Shibagaki Y; Ikuta N; Iguchi S; Takaki K; Watanabe S; Kaihotsu M; Masuda C; Maeyama K; Mizumoto K; Hattori S
    J Virol Methods; 2014 Jun; 202():8-14. PubMed ID: 24613941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication.
    Yuan S; Chu H; Zhang K; Ye J; Singh K; Kao RY; Chow BK; Zhou J; Zheng BJ
    J Antimicrob Chemother; 2016 Sep; 71(9):2489-97. PubMed ID: 27272726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
    Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
    Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen.
    Macdonald SJ; Watson KG; Cameron R; Chalmers DK; Demaine DA; Fenton RJ; Gower D; Hamblin JN; Hamilton S; Hart GJ; Inglis GG; Jin B; Jones HT; McConnell DB; Mason AM; Nguyen V; Owens IJ; Parry N; Reece PA; Shanahan SE; Smith D; Wu WY; Tucker SP
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4542-9. PubMed ID: 15561823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-influenza virus activity of biflavonoids.
    Miki K; Nagai T; Suzuki K; Tsujimura R; Koyama K; Kinoshita K; Furuhata K; Yamada H; Takahashi K
    Bioorg Med Chem Lett; 2007 Feb; 17(3):772-5. PubMed ID: 17110111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the impact of quercetin-7-O-glucoside on influenza virus replication influence.
    Gansukh E; Kazibwe Z; Pandurangan M; Judy G; Kim DH
    Phytomedicine; 2016 Aug; 23(9):958-67. PubMed ID: 27387404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.